CEO Pascal Soriot says AstraZeneca is growing 'new branches' as Covid vaccine sales continue to fall

Nicole DeFeudis

Editor

AstraZeneca CEO Pascal Soriot has been “pruning the tree” for quite some time, cutting a slate of unwanted programs across a range of indications over …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

CEO Pascal Soriot says AstraZeneca is growing 'new branches' as Covid vaccine sales continue to fall

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

A mixed year for deals and dollars left biotech execs hungry for a better 2025

Eli Lilly's Omvoh earns FDA approval for Crohn's disease

#JPM25 live blog day 3: PhRMA chief on reforming the IRA; Gilead weighs in on China dealmaking

FDA explains why it rejected Vanda's stomach drug in late 2024

Vertex's bid to offer Casgevy fertility support is 'self-serving,' HHS says

Oncology biotech plots expedited approval for bone cancer drug after Phase 2 win

CEO Pas­cal So­ri­ot says As­traZeneca is grow­ing 'new branch­es' as Covid vac­cine sales con­tin­ue to fall

Editor

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

CEO Pascal Soriot says AstraZeneca is growing 'new branches' as Covid vaccine sales continue to fall